Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huangqi Guizhi Wuwu Decoction for Oxaliplatin-Induced Peripheral Neurotoxicity
NCT04261920Phase 4Unknown
- Sponsor
- Jiangsu Famous Medical Technology
- Start
- Jan 2020
- Primary completion
- Jan 2023
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 4 trial of huangqi guizhi wuwu decoction in peripheral neuropathy (CIPN), sponsored by Jiangsu Famous Medical Technology. Status: unknown.
02
Drugs
huangqi guizhi wuwu decoction
03
Conditions
peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on NCT04261920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04261920.